Published in JAMA on August 16, 1995
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol (1997) 2.81
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1996) 2.49
Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol (2003) 1.96
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol (1998) 1.53
Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol (1996) 1.37
Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Retrovirology (2013) 1.37
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS (2009) 1.35
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr (2009) 1.27
Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med (2008) 1.23
The HIV RNA setpoint theory revisited. Retrovirology (2007) 1.06
Precise determination of time to reach viral load set point after acute HIV-1 infection. J Acquir Immune Defic Syndr (2012) 1.05
Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics (2007) 1.03
Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire. J Clin Microbiol (1998) 1.03
Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time. PLoS One (2008) 1.01
Should we treat acute HIV infection? Curr HIV/AIDS Rep (2012) 1.00
Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach. PLoS Comput Biol (2011) 0.97
Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. J Virol (1998) 0.96
Association of Y chromosome haplogroup I with HIV progression, and HAART outcome. Hum Genet (2009) 0.94
A simple relationship between viral load and survival time in HIV-1 infection. Proc Natl Acad Sci U S A (1999) 0.92
Can we predict the prognosis of HIV infection? How to use the findings of a prospective study. Sex Transm Infect (1998) 0.92
Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Proc Natl Acad Sci U S A (2006) 0.91
How effectively can HIV phylogenies be used to measure heritability? Evol Med Public Health (2013) 0.85
Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques. J Virol (1999) 0.84
Premature aging and immune senescence in HIV-infected children. AIDS (2016) 0.78
The recombinant maize ribosome-inactivating protein transiently reduces viral load in SHIV89.6 infected Chinese Rhesus Macaques. Toxins (Basel) (2015) 0.77
A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression. PLoS One (2014) 0.77
Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. J Clin Microbiol (1996) 0.77
Percentage of CD4 lymphocytes and risk of AIDS. JAMA (1995) 0.75
Antiretroviral therapy for human immunodeficiency virus infection in 1997. West J Med (1997) 0.75
Dynamics of hybrid switching DS-I-A epidemic model. Sci Rep (2017) 0.75
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science (1999) 8.11
Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80
A cancer family syndrome in twenty-four kindreds. Cancer Res (1988) 6.39
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med (2001) 4.98
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry (1999) 4.22
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77
Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology (2011) 3.62
Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science (1998) 3.60
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care (2001) 3.31
Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int (1984) 3.10
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA (1986) 3.05
Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet (1993) 3.03
Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis (2001) 2.95
No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health (2001) 2.73
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA (1998) 2.55
A STUDY OF A BACTERIAL ASSOCIATION I. THE BIOCHEMISTRY OF THE PRODUCTION OF LACTIC ACID. J Bacteriol (1924) 2.51
Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol (1993) 2.50
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry (1998) 2.46
Genetic polymorphism in CX3CR1 and risk of HIV disease. Science (2000) 2.38
Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med (1983) 2.38
Therapy may explain recent deficits in AIDS incidence. J Acquir Immune Defic Syndr (1990) 2.35
Reduction of self-injurious hand mouthing using response blocking. J Appl Behav Anal (1993) 2.34
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29
Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis (1983) 2.26
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A (2000) 2.24
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med (1987) 2.24
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120. Lancet (1989) 2.12
Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci U S A (1992) 2.05
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med (2001) 2.05
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98
Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science (1988) 1.97
The demographic impact of family planning programs. Stud Fam Plann (1991) 1.97
Marijuana use among HIV-positive and high-risk adolescents: a comparison of self-report through audio computer-assisted self-administered interviewing and urinalysis. Am J Epidemiol (2000) 1.97
Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ (1990) 1.95
"Seeking safety": outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. J Trauma Stress (1998) 1.95
Mortality among chemical workers exposed to benzene and other agents. Environ Res (1983) 1.94
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A (1990) 1.93
Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91
Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91
Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol (1998) 1.90
Teaching persons with profound multiple handicaps: a review of the effects of behavioral research. J Appl Behav Anal (1991) 1.82
Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82
The Navrongo Community Health and Family Planning Project. Stud Fam Plann (1995) 1.81
Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet (1986) 1.80
Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA (2000) 1.79
Integrating health services into an MCH-FP program: lessons from Matlab, Bangladesh. Stud Fam Plann (1984) 1.74
Cultural factors constraining the introduction of family planning among the Kassena-Nankana of northern Ghana. Soc Sci Med (1997) 1.70
Human T-cell leukaemia/lymphoma virus-associated lymphoreticular neoplasia in Jamaica. Lancet (1983) 1.69
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol (1987) 1.69
Normal values for sincalide cholescintigraphy: comparison of two methods. Radiology (2001) 1.67
Familial testicular cancer and urogenital developmental anomalies. Cancer (1985) 1.64
Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr (1993) 1.63
What is safe sex? Suggested standards linked to testing for human immunodeficiency virus. N Engl J Med (1987) 1.63
HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol (1988) 1.63
Women's fears and men's anxieties: the impact of family planning on gender relations in northern Ghana. Stud Fam Plann (1999) 1.63
Population-based monitoring of an urban HIV/AIDS epidemic. Magnitude and trends in the District of Columbia. JAMA (1992) 1.62
Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol (1991) 1.61
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men. J Infect Dis (1999) 1.60
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
Demographic surveillance and health equity in sub-Saharan Africa. Health Policy Plan (2001) 1.59
The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. J Adolesc Health (2001) 1.58
Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med (1989) 1.57
The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis (1989) 1.57
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A (2000) 1.55
Effects of a urinary factor from women in early pregnancy on HIV-1, SIV and associated disease. Nat Med (1998) 1.55
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Effectiveness of community-based screening for depression. Am J Psychiatry (1997) 1.53
Central nervous system bleeding in hemophiliacs. Blood (1978) 1.51
The Household Registration System: computer software for the rapid dissemination of demographic surveillance systems. Demogr Res (2000) 1.51
Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry (1998) 1.49